The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism
β Scribed by Tommaso Bovi; Angelo Antonini; Sarah Ottaviani; Angela Antonioli; Maria Paola Cecchini; Vincenzo Di Francesco; Maria Antonietta Bassetto; Mauro Zamboni; Antonio Fiaschi; Giuseppe Moretto; Andrea Sbarbati; Michele Tinazzi; Francesco Osculati
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 236 KB
- Volume
- 257
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Transcranial sonography (TCS) reveals abnormal spatial extension of substantia nigra (SN) echogenicity in a high proportion of patients with Parkinson's disease (PD). It has been proposed that this abnormality represents a structural trait that is mechanistically distinct from degenerat
Fenfluramine (FE) is a halogenated amphetamine derivative used in the treatment of obesity and thought to induce serotonin (5-HT) release from nerve terminals and to reduce re-uptake. However, other pathways may also be involved. In this work, the effects of FE on the major striatal afferent systems
Administration of 3,5-diethoxycarbonyl-4-ethyl-1,4-dihydro-2,6-dimethylpyridine (4-ethyl-DDC) to hamsters resulted in a marked loss of cytochrome P-450-dependent reactions (peroxidase, 7- ethoxycoumarin O-deethylase, and 7-ethoxyresorufin O-deethylase) in both liver and olfactory epithelium within 2
## Abstract Our objective was to evaluate the ability of neurologists to recognize and diagnose drugβinduced Parkinsonism (DIP) in the elderly. DIP is a diagnostic challenge because it can be indistinguishable from Parkinson's disease, especially in the elderly. It is frequently underβrecognized by